These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3107028)

  • 1. BM-5, a centrally active partial muscarinic agonist with low tremorogenic activity. In vivo and in vitro studies.
    Engström C; Undén A; Ladinsky H; Consolo S; Bartfai T
    Psychopharmacology (Berl); 1987; 91(2):161-7. PubMed ID: 3107028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional differences in receptor reserve for analogs of oxotremorine in vivo: implications for development of selective muscarinic agonists.
    Ringdahl B; Roch M; Jenden DJ
    J Pharmacol Exp Ther; 1987 Aug; 242(2):464-71. PubMed ID: 3612545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacological assessment of RS 86 (2-ethyl-8-methyl-2,8-diazaspiro-[4,5]-decan-1,3-dion hydrobromide). A potent, specific muscarinic acetylcholine receptor agonist.
    Palacios JM; Bolliger G; Closse A; Enz A; Gmelin G; Malanowski J
    Eur J Pharmacol; 1986 Jun; 125(1):45-62. PubMed ID: 3732391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscarinic actions and receptor binding of the enantiomers of BM 130, an alkylating analog of oxotremorine.
    Ringdahl B; Katz ED; Roch M; Jenden DJ
    J Pharmacol Exp Ther; 1989 Apr; 249(1):210-5. PubMed ID: 2709331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urea and 2-imidazolidone derivatives of the muscarinic agents oxotremorine and N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide.
    Nilsson BM; Vargas HM; Hacksell U
    J Med Chem; 1992 Aug; 35(17):3270-9. PubMed ID: 1507212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual effect of N-methyl-N-(1-methyl-4-pyrolidino)-2-butyl)acetamide on release of (3H)-acetylcholine from the rat hippocampal slices.
    Sethy VH; Francis JW; Russell RR; Ruppel PL
    Neuropharmacology; 1988 Nov; 27(11):1191-5. PubMed ID: 3205386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselective binding and activity of oxotremorine analogs at muscarinic receptors in rat brain.
    Messer WS; Ngur DO; Abuh YF; Dokas LA; Ting SM; Hacksell U; Nilsson BM; Dunbar PG; Hoss W
    Chirality; 1992; 4(8):463-8. PubMed ID: 1476855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscarinic actions of an N-methyl-N-2-bromoethylamino analog of oxotremorine (BR 401) in the mouse.
    Ringdahl B; Jenden DJ
    J Pharmacol Exp Ther; 1987 Feb; 240(2):370-5. PubMed ID: 3806401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformationally restricted analogues of the muscarinic agent N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide.
    Lundkvist JR; Ringdahl B; Hacksell U
    J Med Chem; 1989 Apr; 32(4):863-9. PubMed ID: 2704032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Methyl-2-pyrrolidone analogues of oxotremorine as selective muscarinic agonists.
    Ringdahl B
    J Med Chem; 1988 Mar; 31(3):683-8. PubMed ID: 3346881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presynaptic antagonist-postsynaptic agonist at muscarinic cholinergic synapses. N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide.
    Nordström O; Alberts P; Westlind A; Undén A; Bartfai T
    Mol Pharmacol; 1983 Jul; 24(1):1-5. PubMed ID: 6306436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of BM-5, a presynaptic antagonist-postsynaptic agonist, on cortical acetylcholine release.
    Casamenti F; Cosi C; Pepeu G
    Eur J Pharmacol; 1986 Mar; 122(2):288-90. PubMed ID: 3011445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonergic potentiation of muscarinic agonist evoked tremor and salivation in rat and mouse.
    Ogren SO; Carlsson S; Bartfai T
    Psychopharmacology (Berl); 1985; 86(3):258-64. PubMed ID: 3929296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical and biochemical studies of 2-propynylpyrrolidine derivatives. Restricted-rotation analogues of N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide (BM-5).
    Trybulski EJ; Kramss RH; Mangano RM; Rusinko A
    J Med Chem; 1990 Dec; 33(12):3190-8. PubMed ID: 2258905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral and physiological effects associated with changes in muscarinic receptors following administration of an irreversible cholinergic agonist (BM 123).
    Russell RW; Smith CA; Booth RA; Jenden DJ; Waite JJ
    Psychopharmacology (Berl); 1986; 90(3):308-15. PubMed ID: 3097716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel alkoxy-oxazolyl-tetrahydropyridine muscarinic cholinergic receptor antagonists.
    Shannon HE; Bymaster FP; Hendrix JC; Quimby SJ; Mitch CH
    Psychopharmacology (Berl); 1995 Jan; 117(2):208-15. PubMed ID: 7753969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacological assessment of a new, potent oxotremorine analogue in mice and rats.
    Resul B; Lewander T; Ringdahl B; Zetterström T; Dahlbom R
    Eur J Pharmacol; 1982 May; 80(2-3):209-15. PubMed ID: 7106176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic scopolamine treatment and brain cholinergic function.
    Marks MJ; O'Connor MF; Artman LD; Burch JB; Collins AC
    Pharmacol Biochem Behav; 1984 May; 20(5):771-7. PubMed ID: 6739517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vivo effects of parathion on striatal acetylcholine accumulation in adult and aged rats.
    Karanth S; Liu J; Ray A; Pope C
    Toxicology; 2007 Oct; 239(3):167-79. PubMed ID: 17707571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.
    Shannon HE; Bymaster FP; Calligaro DO; Greenwood B; Mitch CH; Sawyer BD; Ward JS; Wong DT; Olesen PH; Sheardown MJ; Swedberg MD; Suzdak PD; Sauerberg P
    J Pharmacol Exp Ther; 1994 Apr; 269(1):271-81. PubMed ID: 7909557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.